Financials
Value Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 159 M167 M173 M — Research & development 92 M90 M94 M — Operating income 272 M40 M472 M — Non-Operating Income, Total -1 M14 M-5 M — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 011 M-6 M — Unusual income/expense -1 M3 M1 M — Pretax income 272 M189 M218 M — Equity in earnings 15 M10 M13 M — Taxes 49 M80 M56 M — Non-controlling/minority interest 12 M9 M11 M — After tax other income/expense ——-9 M — Net income before discontinued operations 211 M109 M162 M — Discontinued operations ——— — Net income 211 M109 M162 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders 211 M100 M151 M — Basic earnings per share (Basic EPS) 1.010.470.72 — Diluted earnings per share (Diluted EPS) 1.010.470.72 — Average basic shares outstanding 209 M209.6 M209.7 M — Diluted shares outstanding 209 M209.8 M210.3 M — EBITDA 367 M161 M598 M — EBIT 273 M65 M500 M — Cost of revenue 701 M641 M697 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 94 M96 M98 M —